New model could help breast cancer patients know their fertility future
NCT ID NCT07497191
First seen Apr 05, 2026 · Last updated May 20, 2026 · Updated 5 times
Summary
This study aims to create a tool that uses changes in a hormone called AMH to predict whether perimenopausal women with breast cancer will enter menopause after treatment. About 300 women aged 45-55 will have blood samples taken at seven different times. The goal is to help doctors choose the right hormone therapy and give personalized advice about fertility preservation.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.